vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and First Western Financial Inc (MYFW). Click either name above to swap in a different company.
First Western Financial Inc is the larger business by last-quarter revenue ($27.5M vs $21.2M, roughly 1.3× Autolus Therapeutics plc).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
AUTL vs MYFW — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $27.5M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | — |
| Operating Margin | -337.9% | — |
| Net Margin | -373.3% | — |
| Revenue YoY | — | — |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $27.5M | ||
| Q4 25 | — | $26.7M | ||
| Q3 25 | $21.2M | $26.3M | ||
| Q2 25 | $20.9M | $24.2M | ||
| Q1 25 | $9.0M | $24.8M | ||
| Q4 24 | — | $24.3M | ||
| Q3 24 | $0 | $22.5M | ||
| Q2 24 | $0 | $22.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.3M | ||
| Q3 25 | $-79.1M | $3.2M | ||
| Q2 25 | $-47.9M | $2.5M | ||
| Q1 25 | $-70.2M | $4.2M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-82.1M | $2.1M | ||
| Q2 24 | $-58.3M | $1.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 16.6% | ||
| Q3 25 | -337.9% | 15.1% | ||
| Q2 25 | -292.6% | 13.7% | ||
| Q1 25 | -726.3% | 21.6% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | — | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.9% | ||
| Q3 25 | -373.3% | 12.1% | ||
| Q2 25 | -229.0% | 10.3% | ||
| Q1 25 | -781.1% | 16.9% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 9.5% | ||
| Q2 24 | — | 4.7% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | — | $0.33 | ||
| Q3 25 | $-0.30 | $0.32 | ||
| Q2 25 | $-0.18 | $0.26 | ||
| Q1 25 | $-0.26 | $0.43 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | $-0.31 | $0.22 | ||
| Q2 24 | $-0.22 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $273.4M |
| Total Assets | $661.9M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $273.4M | ||
| Q4 25 | — | $265.6M | ||
| Q3 25 | $265.5M | $261.5M | ||
| Q2 25 | $346.5M | $258.8M | ||
| Q1 25 | $371.1M | $256.6M | ||
| Q4 24 | — | $252.3M | ||
| Q3 24 | $477.0M | $248.8M | ||
| Q2 24 | $527.8M | $246.9M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | $661.9M | $3.2B | ||
| Q2 25 | $721.0M | $3.0B | ||
| Q1 25 | $746.3M | $2.9B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | $827.5M | $2.9B | ||
| Q2 24 | $853.6M | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | — |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-67.9M | $10.0M | ||
| Q2 25 | $-72.8M | $-9.1M | ||
| Q1 25 | $-75.6M | $8.0M | ||
| Q4 24 | — | $606.0K | ||
| Q3 24 | $-76.7M | $18.8M | ||
| Q2 24 | $-51.1M | $-11.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-5.8M | ||
| Q3 25 | $-72.3M | $9.0M | ||
| Q2 25 | $-80.1M | $-9.7M | ||
| Q1 25 | $-83.8M | $7.0M | ||
| Q4 24 | — | $-607.0K | ||
| Q3 24 | $-86.3M | $18.6M | ||
| Q2 24 | $-51.9M | $-11.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | -21.6% | ||
| Q3 25 | -341.2% | 34.1% | ||
| Q2 25 | -382.6% | -39.9% | ||
| Q1 25 | -933.1% | 28.1% | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -52.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 14.9% | ||
| Q3 25 | 20.8% | 4.1% | ||
| Q2 25 | 34.8% | 2.4% | ||
| Q1 25 | 91.8% | 4.2% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -0.54× | ||
| Q3 25 | — | 3.15× | ||
| Q2 25 | — | -3.63× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 8.83× | ||
| Q2 24 | — | -10.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
MYFW
| Net Interest Income | $20.9M | 76% |
| Noninterest Income | $6.7M | 24% |
